§ 522.1083. Gonadotropin releasing factor analog-diphtheria toxoid conjugate.
180 words·~1 min read·
/us/cfr/t21/s§ 522.1083A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Specifications. Each milliliter
(mL)of solution contains 0.2 milligrams
(mg)gonadotropin releasing factor analog-diphtheria toxoid conjugate.
(b)Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c)Conditions of use in swine—(1) Amount. Each intact male pig or gilt should receive two 2-mL (0.4 mg) doses by subcutaneous injection. Administer the first dose no earlier than 9 weeks of age. Administer the second dose at least 4 weeks after the first dose.
(2)Indications for use—(i) Intact male pigs intended for slaughter: For the temporary immunological castration (suppression of testicular function) and reduction of boar taint.
(ii)Gilts intended for slaughter: For the temporary suppression of estrus.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For reduction of boar taint, intact male pigs should be slaughtered no earlier than 3 weeks and no later than 10 weeks after the second dose. [76 FR 27889, May 13, 2011, as amended at 77 FR 4227, Jan. 27, 2012; 79 FR 16189, Mar. 25, 2014; 85 FR 45308, July 28, 2020]
Connections1 cite this
Cited by 1 section
register
Citation graph
cites case law
§ 522.1083
Gonadotropin releasing factor analog-diphtheria toxoid conjugate.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source